TY - JOUR
T1 - Pathologische Frakturen des Humerus
T2 - Erfahrungen an 76 Fällen eines muskuloskeletalen Tumorzentrums
AU - Toepfer, A.
AU - Lenze, U.
AU - Pohlig, F.
AU - Eisenhart-Rothe, R. Von
AU - Gerdesmeyer, L.
AU - Kirchhoff, C.
AU - Harrasser, N.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background: Pathological fractures can be caused by numerous local and systemic processes. The humerus is one of the commonest sites of pathological, tumour-associated fractures. Patients and Methods: In a retrospective study, 76 cases of pathological fractures of the humerus were analysed; 57 (75 %) were caused by a malignant disease, 19 fractures were associated with benign musculoskeletal disorders (25 %). The grade of the tumour, treatment strategy, intra- and postoperative complications, and survival rates in malignant tumours were documented. Results: Two thirds of fractures were localised in the proximal third of the humerus. In 59 % of patients, malignant lesions were metastases (mainly renal cell, breast, lung and prostate cancer), followed by haemato-oncological diseases and primary sarcomas. Most benign tumours were simple bone cysts and enchondromas. A total of 70 patients were treated surgically and only 6 conservatively. Most malignant tumours were treated with compound osteosynthesis and tumour prostheses. Complications in both groups were rare. Conclusion: The demographic transition - with an increasing number of malignancies on the one hand and improved life expectancy under modern, adjuvant therapies on the other - will become a challenge in the treatment of pathological fractures of the humerus for a variety of disciplines.
AB - Background: Pathological fractures can be caused by numerous local and systemic processes. The humerus is one of the commonest sites of pathological, tumour-associated fractures. Patients and Methods: In a retrospective study, 76 cases of pathological fractures of the humerus were analysed; 57 (75 %) were caused by a malignant disease, 19 fractures were associated with benign musculoskeletal disorders (25 %). The grade of the tumour, treatment strategy, intra- and postoperative complications, and survival rates in malignant tumours were documented. Results: Two thirds of fractures were localised in the proximal third of the humerus. In 59 % of patients, malignant lesions were metastases (mainly renal cell, breast, lung and prostate cancer), followed by haemato-oncological diseases and primary sarcomas. Most benign tumours were simple bone cysts and enchondromas. A total of 70 patients were treated surgically and only 6 conservatively. Most malignant tumours were treated with compound osteosynthesis and tumour prostheses. Complications in both groups were rare. Conclusion: The demographic transition - with an increasing number of malignancies on the one hand and improved life expectancy under modern, adjuvant therapies on the other - will become a challenge in the treatment of pathological fractures of the humerus for a variety of disciplines.
KW - bone metastasis
KW - bone tumour
KW - compound osteosynthesis
KW - humerus
KW - pathologic fracture
UR - http://www.scopus.com/inward/record.url?scp=84973664475&partnerID=8YFLogxK
U2 - 10.1055/s-0042-105160
DO - 10.1055/s-0042-105160
M3 - Artikel
C2 - 27273274
AN - SCOPUS:84973664475
SN - 1864-6697
VL - 154
SP - 364
EP - 369
JO - Zeitschrift fur Orthopadie und Unfallchirurgie
JF - Zeitschrift fur Orthopadie und Unfallchirurgie
IS - 4
ER -